^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    CMTM4 expression + PD-L1 expression

    i
    Other names: CMTM4, CKLF Like MARVEL Transmembrane Domain Containing 4, CKLFSF4, CKLF-Like MARVEL Transmembrane Domain-Containing Protein 4, Chemokine-Like Factor Superfamily Member 4, Chemokine-Like Factor Super Family 4, CKLF-Like MARVEL Transmembrane Domain Containing 4, Chemokine-Like Factor Superfamily 4, PD-L1, CD274, HPD-L1, PD-L1, B7H1, PDL1, Programmed death ligand 1, B7-H1, B7-H, PDCD1L1, PDCD1LG1, PDCD1 Ligand 1, B7 homolog 1, CD274 Antigen, Programmed cell death 1 ligand 1, CD274 molecule
    Entrez ID:
    29126; 146223
    Related biomarkers:
    Expression
    Mutation
    CNA
    Others
    2years
    Prognostic significance and immune characteristics of CMTM4 in hepatocellular carcinoma. (PubMed, BMC Cancer)
    CMTM4 and PD-L1 co-expression with T cell infiltration shows prognostic significance in HCC, suggesting combined effect from multiple proteins should be considered in HCC treatment.
    Journal • PD(L)-1 Biomarker • IO biomarker
    |
    CD8 (cluster of differentiation 8) • CD4 (CD4 Molecule) • CMTM4 (CKLF Like MARVEL Transmembrane Domain Containing 4)
    |
    PD-L1 expression • CMTM4 expression + PD-L1 expression